From Name:
From Email:
To Name:
To Email:

Optional Message:

Study shows potential of whole genome sequencing and AI to help clinicians scale precision oncology

from News-Medical

In a study published recently in the July 11, 2017, issue of Neurology Genetics, an official journal of the American Academy of Neurology, researchers at the New York Genome Center, The Rockefeller University and other NYGC member institutions, and IBM have illustrated the potential of IBM Watson for Genomics to analyze complex genomic data from state-of-the-art DNA sequencing of whole genomes. The study compared multiple techniques — or assays — used to analyze genomic data from a glioblastoma patient's tumor cells and normal healthy cells. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063